$NAVB $2.04 at breakout resistance PR
Post# of 63696
Shares Outstanding 134,345,483 a/o Nov 05, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
FDA Grants Fast Track Designation
To Navidea Biopharma's Lymphoseek Injection
12/10/2013 7:39:00 AM - RTT News